Wrist Tracker vs Waist Monitor: How Well Do They Count Sitting Time in Heart Patients?

A recent study looked at how well a cheap wrist tracker matches a more precise waist accelerometer when counting sitting time for people with heart problems in Japan. The researchers recruited 51 patients who were either dealing with heart failure or blocked arteries. Their average age was about 78 years, and just under half were men. The goal was to see if the simple device could replace the lab‑grade tool in everyday care.

Both gadgets were worn at the same time for a full week while participants went about their normal days. The tracking covered a 12‑hour stretch from 9 a.m. to 9 p.m., breaking the data into one‑minute blocks. To compare the two sets of numbers, the team used several statistical checks: Pearson’s r, a Bland‑Altman plot, Lin’s concordance coefficient, and Cohen’s kappa for how often the devices placed patients in the same thirds of sitting time. They also applied a fixed bias fix and ran a leave‑one‑out cross‑validation to see if the bias stayed stable across the group. Other factors that might change the bias were examined with a multi‑variable model.

On average, the reference waist device recorded about 498 minutes of sitting during the daytime window, while the wrist tracker logged roughly 560 minutes. That means the wrist gadget counted about 62 minutes more than the gold‑standard tool. The statistical links between the two measurements were strong, showing the devices tended to move together even though the wrist model consistently reported higher values. The bias correction helped shrink the gap, and the cross‑validation confirmed the adjustment was reliable across the sample.

The findings suggest that a consumer wrist tracker can give a rough idea of how much time heart patients spend sitting, but it overestimates compared with a research‑grade accelerometer. Clinicians should be aware of this systematic overcount when using the simpler device for routine monitoring. The study also highlights the value of checking the bias with real‑world data before relying on the numbers for treatment decisions.